Omnicell to Release Third Quarter 2026 Financial Results on October 29, 2026
Omnicell (OMCL) will release its third-quarter 2026 financial results before market open on October 29, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
All interested parties are invited to listen to the live call and presentation by dialing (833) 461-5787 in the
About Omnicell
Since 1992, Omnicell has been committed to delivering innovative, outcomes-centric pharmacy and nursing solutions for all settings of care. As an intelligent medication management technology company, Omnicell empowers autonomous medication management by unifying automation and AI-enabled intelligence, optimized by expert services, to drive clinical and business outcomes that are helping to improve efficiency and enhance patient safety for healthcare facilities worldwide. Learn more at omnicell.com.
OMNICELL and the Omnicell logo are registered trademarks of Omnicell, Inc. or one of its subsidiaries.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261008405269/en/
Investor Relations Contact
David Unger
VP, Investor Relations
Omnicell, Inc.
ir@omnicell.com
Source: Omnicell, Inc.